Vaccine News: National Institute For Allergies And Infectious Diseases Research Indicates That Moderna’s COVID-19 Vaccine Provides Three-Month Immunity.

Home / News / Vaccine News: National Institute For Allergies And Infectious Diseases Research Indicates That Moderna’s COVID-19 Vaccine Provides Three-Month Immunity.


https://www.thailandmedical.news/news/vaccine-news-national-institute-for-allergies-and-infectious-diseases-research-indicates-that-moderna-s-covid-19-vaccine-provides-three-month-immunit



            
                
                                            Recent News
COVID-19 News: America Finally Has Its Own SARS-CoV-2 Variant COH.20G/501Y with More Worst and Complex Variants to Debut Shortly!
Vaccine News: 23 Deaths From Pfizer’s COVID-19 Vaccine in Norway, Chinese Urges Halt to mRNA Vaccines, Legal Suits for Those Saying Vaccines are Safe!
Vaccine News: Pfizer’s Study on Vaccine Effectiveness Against New Variants and Claims are Misleading, Numerous Professional Experts Aghast.
Breaking! COVID-19 News: Japan Discovers New SARS-CoV-2 Variant Originating from Brazil, The B.1.1.248 Variant with 12 Spike Mutations!
Sinopharm’s COVID-19 vaccine scores approval in China
			
	
		
	



	
		About Us
	
	
		
	



	
		In 1993, Biogenetech started with just 10 staff, distributing diagnostic kits and nuclear medicines.

In the past 25 years, Biogenetech introduced more than 15 innovative vaccines and pharmaceuticals, contributing to the improvements in public health standards in Thailand, protecting our population from numerous infectious diseases!

	



	
	Read More


        

        
                    
                
                    Related Health Education
                                        
                        
                            
                                
                                    Vaccine News: 23 Deaths From Pfizer’s COVID-19 Vaccine in Norway, Chinese Urges Halt to mRNA Vaccines, Legal Suits for Those Saying Vaccines are Safe!                                
                            
                        
                                        
                        
                            
                                
                                    Vaccine News: Pfizer’s Study on Vaccine Effectiveness Against New Variants and Claims are Misleading, Numerous Professional Experts Aghast.                                
                            
                        
                                        
                        
                            
                                
                                    Breaking! COVID-19 News: Japan Discovers New SARS-CoV-2 Variant Originating from Brazil, The B.1.1.248 Variant with 12 Spike Mutations!                                
                            
                        
                                        
                        
                            
                                
                                    Sinopharm’s COVID-19 vaccine scores approval in China                                
                            
                        
                                        
                        
                            
                                
                                    Covid: What do we know about China’s coronavirus vaccines?

Related Posts

Vaccine News: National Institute For Allergies And Infectious Diseases Research Indicates That Moderna’s COVID-19 Vaccine Provides Three-Month Immunity.

Related Health Education